WISSENSCHAFT & FORSCHUNG

Wissenschaft &
Forschung

Evidenzbasierte Medizin. Internationale Forschung. Globale Lehre.

0
Publikationen
0
Zitierungen
0
H-Index
0
Gelesene Arbeiten

Forschungswirkung

Was diese Zahlen bedeuten

15.300+ Zitierungen

So oft wurden die Arbeiten von Univ.-Prof. Dr. Gerhard Prager in anderen wissenschaftlichen Publikationen referenziert. Zitierungen sind der wichtigste Indikator dafür, dass Forschungsergebnisse von der wissenschaftlichen Gemeinschaft aufgegriffen und weiterentwickelt werden.

H-Index 63

Der H-Index misst sowohl Produktivität als auch Wirkung: Ein H-Index von 63 bedeutet, dass mindestens 63 Publikationen jeweils mindestens 63-mal zitiert wurden. Er gilt als das aussagekräftigste Maß für den nachhaltigen Einfluss eines Wissenschaftlers.

75.000+ Leser

Über 75.000-mal wurden die Arbeiten von Fachkollegen weltweit gelesen. Diese Zahl zeigt die internationale Reichweite und Relevanz der Forschung in der täglichen klinischen Praxis.

Research Interest Score 7.575,5

Der RI-Score von ResearchGate bewertet das Interesse der wissenschaftlichen Gemeinschaft an der Forschung eines Wissenschaftlers. Ein Wert von 7.575,5 liegt höher als 99% aller Forscher weltweit - ein Zeichen außergewöhnlicher wissenschaftlicher Wirkung.

Schwerpunkte

Forschungsschwerpunkte

01

Bariatrisch-Metabolische Chirurgie

Mechanismen der Gewichtsreduktion und Diabetes-Remission nach bariatrischen Eingriffen. Langzeit-Outcomes und Vergleich verschiedener OP-Techniken. Hormonelle Veränderungen und deren Einfluss auf den Stoffwechsel.

02

Endokrine Chirurgie

Minimal-invasive Techniken in der Schilddrüsen- und Nebenschilddrüsenchirurgie. Neuromonitoring zur Schonung des Stimmnervs. Weiterentwicklung laparoskopischer Zugänge bei Nebennierentumoren.

03

Magen-Darm-Leber-Achse

NASH/NAFLD und bariatrische Chirurgie als therapeutische Option. Einfluss von Gewichtsverlust auf Leberentfettung und Fibrosereduktion. Interaktion zwischen Darmmikrobiom und metabolischer Gesundheit.

Ausbildung

Lehrtätigkeit & Ausbildung

Clinical Immersions am AKH Wien

Hospitationsprogramme für Chirurgen aus aller Welt. Begleitung im klinischen Alltag, OP-Beobachtung und wissenschaftlicher Austausch.

IRCAD Straßburg

Regelmäßiger Kursleiter am weltweit führenden Ausbildungszentrum für minimal-invasive Chirurgie. Hands-on-Training für internationale Chirurgen.

Masterclass in Bariatric Surgery

Jährliche Masterclass in Wien für fortgeschrittene bariatrische Chirurgen. Kombination aus Theorie, Live-Operationen und Falldiskussionen.

50+ Länder

Chirurgen aus über 50 Ländern wurden von Univ.-Prof. Dr. Gerhard Prager ausgebildet - in Wien, Straßburg und bei internationalen Kongressen weltweit.

IFSO Karriere

Weg zum Weltpräsidenten

2011
Wiss. Beirat
2018
EC-Präsident
2021
President-Elect
2023
Weltpräsident
Aktuell
Past President

Publikationsliste

Wissenschaftliche Publikationen

Ausgewählte Publikationen aus über 35 Jahren Forschung in bariatrisch-metabolischer und endokriner Chirurgie.

237 Publikationen

2026

  • Mohajer-Bastami, A., et al., A Critical Analysis of Transformational Leadership and How It Can Improve Culture and Service Outcomes Within the Health Care System. J Patient Saf, 2026. 22(1): p. 73-77.
  • Kermansaravi, M., et al., Same-day Discharge Metabolic and Bariatric Surgery: a GRADE-based International Federation for the Surgery and Other Therapies for Obesity (IFSO) Position Statement. Obes Surg, 2026.
  • Kartnig, F.I., et al., N-terminal pro B-type natriuretic peptide increase after bariatric surgery is linked to decreased insulin resistance and is more pronounced in women. Surg Obes Relat Dis, 2026. 22(1): p. 106-112.
  • Gensthaler, L., et al., A Case Series and Technical Note on Endoluminal Vacuum Therapy via Pull-Through Technique for Leakage after Metabolic Bariatric Surgery. Obes Surg, 2026.
  • Felsenreich, D.M. and G. Prager, [Metabolic/bariatric surgery is effective : What is the evidence regarding hard endpoints and long-term outcomes?]. Chirurgie (Heidelb), 2026. 97(1): p. 4-10.
  • Cohen, R.V., et al., The International Federation for Surgery and Other Therapies for Obesity (IFSO) Consensus on Clinical Practice in Endoscopic Sleeve Gastroplasty. Obes Surg, 2026.

2025

  • Scherer, T., et al., A direct effect of the hematocrit on blood glucose: Evidence from hypoxia- and erythropoietin-treated mice. Sci Adv, 2025. 11(16): p. eadt7366.
  • Mairinger, M., et al., Progression of liver fibrosis after metabolic bariatric surgery in a MASLD rat model. Clin Nutr, 2025. 52: p. 225-233.
  • Lehner, L., et al., Health Status and Patients' Satisfaction on the Long Term after Metabolic/Bariatric Surgery. Obes Facts, 2025: p. 1-9.
  • Kermansaravi, M., et al., AI-assisted assessment of the IFSO consensus on obesity management medications in the context of metabolic bariatric surgery. PLOS Digit Health, 2025. 4(12): p. e0001132.
  • Kermansaravi, M., et al., International expert consensus on surgery for type 2 diabetes mellitus. BMC Endocr Disord, 2025. 25(1): p. 151.
  • Kermansaravi, M., et al., International expert consensus on the current status and future prospects of artificial intelligence in metabolic and bariatric surgery. Sci Rep, 2025. 15(1): p. 9312.
  • Kermansaravi, M., et al., One anastomosis gastric bypass in children and adolescents: An international expert survey. Clin Obes, 2025. 15(5): p. e70018.
  • Joerg, R., et al., The effect of long-chain n-3 PUFA on liver transcriptome in human obesity. Prostaglandins Leukot Essent Fatty Acids, 2025. 204: p. 102663.
  • Herz, C.T., et al., Bariatric surgery promotes recruitment of brown fat linked to alterations in the gut microbiota. Eur J Endocrinol, 2025. 192(5): p. 603-611.
  • Felsenreich, D.M., et al., Update on esophageal function, acid and non-acid reflux after one-anastomosis gastric bypass (OAGB): high-resolution manometry, impedance-24-h pH-metry, and gastroscopy in a prospective mid-term study. Surg Endosc, 2025. 39(4): p. 2335-2345.
  • Dominik, N., et al., UDFF and Auto pSWE accurately assess liver steatosis and fibrosis risk in obese patients with MASLD. Ultraschall Med, 2025.
  • De Luca, M., et al., Meta-analysis of randomized controlled trials for the development of the International Federation for Surgery of Obesity and Metabolic Disorders-European Chapter (IFSO-EC) guidelines on multimodal strategies for the surgical treatment of obesity. Diabetes Obes Metab, 2025. 27(6): p. 3347-3356.
  • Cohen, R.V., G. Prager, and P. Salminen, Obesity is more than a number: a framework for treatment. Br J Surg, 2025. 112(5).
  • Cohen, R.V., et al., International Federation for the Surgery of Obesity statement on metabolic bariatric surgery after pharmacotherapy-induced weight loss in clinical obesity. Lancet Diabetes Endocrinol, 2025. 13(9): p. 733-736.
  • Cohen, R.V., et al., International Federation for the Surgery and Other Therapies for Obesity (IFSO) global consensus recommendations for optimizing outcomes after sleeve gastrectomy. Br J Surg, 2025. 112(10).

2024

  • Salminen, P., et al., IFSO Consensus on Definitions and Clinical Practice Guidelines for Obesity Management-an International Delphi Study. Obes Surg, 2024. 34(1): p. 30-42.
  • Ponce de Leon-Ballesteros, G., et al., Single Anastomosis Duodeno-Ileostomy with Sleeve Gastrectomy/Single Anastomosis Duodenal Switch (SADI-S/SADS) IFSO Position Statement-Update 2023. Obes Surg, 2024. 34(10): p. 3639-3685.
  • Ponce de Leon-Ballesteros, G., et al., Metabolic and Bariatric Surgery in Patients with Obesity Class V (BMI > 60 kg/m(2)): a Modified Delphi Study. Obes Surg, 2024.
  • Nixdorf, L., et al., Rapid improvement of hepatic steatosis and liver stiffness after metabolic/bariatric surgery: a prospective study. Sci Rep, 2024. 14(1): p. 17558.
  • Kermansaravi, M., et al., Metabolic and Bariatric Surgeon Criteria-An International Experts' Consensus. Obes Surg, 2024. 34(9): p. 3216-3228.
  • Kermansaravi, M., et al., Revision/Conversion Surgeries After One Anastomosis Gastric Bypass-An Experts' Modified Delphi Consensus. Obes Surg, 2024. 34(7): p. 2399-2410.
  • Haddad, A., et al., Therapeutic Options for Recurrence of Weight and Obesity Related Complications After Metabolic and Bariatric Surgery: An IFSO Position Statement. Obes Surg, 2024. 34(11): p. 3944-3962.
  • Gensthaler, L., et al., Endoluminal Vacuum Therapy as Effective Treatment for Patients with Postoperative Leakage After Metabolic Bariatric Surgery-A Single-Center Experience. Obes Surg, 2024. 34(9): p. 3306-3314.
  • De Luca, M., et al., Scientific evidence for the updated guidelines on indications for metabolic and bariatric surgery (IFSO/ASMBS). Surg Obes Relat Dis, 2024. 20(11): p. 991-1025.
  • De Luca, M., et al., Scientific Evidence for the Updated Guidelines on Indications for Metabolic and Bariatric Surgery (IFSO/ASMBS). Obes Surg, 2024. 34(11): p. 3963-4096.
  • De Luca, M., et al., Development of the International Federation for Surgery of Obesity and Metabolic Disorders-European Chapter (IFSO-EC) Grade-Based Guidelines on the Surgical Treatment of Obesity Using Multimodal Strategies: Design and Methodological Aspects. J Clin Med, 2024. 13(17).
  • Dayyeh, B.K.A., et al., IFSO Bariatric Endoscopy Committee Evidence-Based Review and Position Statement on Endoscopic Sleeve Gastroplasty for Obesity Management. Obes Surg, 2024.
  • Cohen, R.V., et al., Role of obesity-management medications before and after metabolic bariatric surgery: a systematic review. Br J Surg, 2024. 111(12).
  • Cohen, R.V., et al., International consensus position statement on the role of obesity management medications in the context of metabolic bariatric surgery: expert guideline by the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). Br J Surg, 2024. 111(12).
  • Abu Dayyeh, B.K., et al., Correction: IFSO Bariatric Endoscopy Committee Evidence-Based Review and Position Statement on Endoscopic Sleeve Gastroplasty for Obesity Management. Obes Surg, 2024.

2023

  • Ulbing, S., et al., Author's Reply to the "Letter to the Editor Regarding 'The Performance of Opioid-Free Anesthesia for Bariatric Surgery in Clinical Practice'". Obes Surg, 2023.
  • Jedamzik, J., et al., The male patient with obesity undergoing metabolic and bariatric surgery: changes in testosterone levels correlate with weight loss after one-anastomosis gastric bypass and Roux-en-Y gastric bypass. Surg Obes Relat Dis, 2023. 19(7): p. 699-705.
  • Ghobrial, S., et al., Outcome of Gastric Bypass Surgery on Patients with Polycystic Ovary Syndrome: A Review. J Clin Med, 2023. 12(12).
  • Felsenreich, D.M., et al., Potential Risk of Hypoglycaemia in Gastric Bypass Patients with Their Profession in Public Transportation System. Obes Surg, 2023. 33(11): p. 3687-3688.
  • Felsenreich, D.M., et al., [Indications and preoperative planning for bariatric surgery]. Wien Klin Wochenschr, 2023. 135(Suppl 6): p. 721-728.
  • Felsenreich, D.M., et al., Intrathoracic pouch migration in one-anastomosis gastric bypass with and without hiatoplasty: A 3-dimensional-computed tomography volumetry study. Surg Obes Relat Dis, 2023. 19(5): p. 492-499.
  • Brix, J.M., et al., [Overweight and obesity in adults: general principles of treatment and conservative management]. Wien Klin Wochenschr, 2023. 135(Suppl 6): p. 706-720.
  • Beiglbock, H., et al., The Timing of Pregnancies After Bariatric Surgery has No Impact on Children's Health-a Nationwide Population-based Registry Analysis. Obes Surg, 2023. 33(1): p. 149-155.

2022

  • Walter, E., et al., Impact of metabolic surgery on cost and long-term health outcome: a cost-effectiveness approach. Surg Obes Relat Dis, 2022. 18(2): p. 260-270.
  • Salminen, P., G. Prager, and P.R. Schauer, Is COVID-19 the Newest Comorbidity of Obesity Mitigated by Bariatric Surgery? JAMA Surg, 2022. 157(3): p. 230.
  • Ranzenberger-Haider, T., et al., Evaluation of a Bariatric Monitoring Pass for Primary Care Physicians. Obes Facts, 2022. 15(5): p. 629-637.
  • Nixdorf, L., et al., Surgical Technique for Weight Regain after Roux-en-Y Gastric Bypass: Pouch-resizing and the MiniMIZER(R) Gastric Ring. Surg Technol Int, 2022. 41.
  • Kulterer, O.C., et al., Brown Adipose Tissue Prevalence Is Lower in Obesity but Its Metabolic Activity Is Intact. Front Endocrinol (Lausanne), 2022. 13: p. 858417.
  • Kermansaravi, M., et al., Patient Selection in One Anastomosis/Mini Gastric Bypass-an Expert Modified Delphi Consensus. Obes Surg, 2022. 32(8): p. 2512-2524.
  • Jedamzik, J., D.M. Felsenreich, and G. Prager, Reply to comment on: Conversion from one-anastomosis gastric bypass to Roux-en-Y gastric bypass. Surg Obes Relat Dis, 2022. 18(5): p. 675-676.
  • Jedamzik, J., et al., Conversion from one-anastomosis gastric bypass to Roux-en-Y gastric bypass: when and why-a single-center experience of all consecutive OAGB procedures. Surg Obes Relat Dis, 2022. 18(2): p. 225-232.
  • Herz, C.T., et al., Obesity is associated with a higher Torque Teno viral load compared to leanness. Front Endocrinol (Lausanne), 2022. 13: p. 962090.
  • Gensthaler, L., et al., Trends of Overweight and Obesity in Male Adolescents: Prevalence, Socioeconomic Status, and Impact on Cardiovascular Risk in a Central European Country. Obes Surg, 2022. 32(4): p. 1024-1033.
  • Felsenreich, D.M., et al., Outcome of Sleeve Gastrectomy Converted to Roux-en-Y Gastric Bypass and One-Anastomosis Gastric Bypass. Obes Surg, 2022. 32(3): p. 643-651.
  • Felsenreich, D.M., et al., Reply to the Letter to the Editor Concerning Outcome of Sleeve Gastrectomy to Roux-en-Y Gastric Bypass and One-Anastomosis Gastric Bypass. Obes Surg, 2022. 32(8): p. 2793-2794.
  • Felsenreich, D.M., et al., Fifteen Years after Sleeve Gastrectomy: Gastroscopies, Manometries, and 24-h pH-Metries in a Long-Term Follow-Up: A Multicenter Study. Obes Facts, 2022. 15(5): p. 666-673.
  • Eichelter, J., et al., Surgical Technique of Single Anastomosis Duodeno-Ileal Bypass with Sleeve Gastrectomy (SADI-S). Surg Technol Int, 2022. 41.
  • Carrano, F.M., et al., EAES rapid guideline: systematic review, network meta-analysis, CINeMA and GRADE assessment, and European consensus on bariatric surgery-extension 2022. Surg Endosc, 2022. 36(3): p. 1709-1725.
  • Beiglbock, H., et al., Sex-Specific Differences in Mortality of Patients with a History of Bariatric Surgery: a Nation-Wide Population-Based Study. Obes Surg, 2022. 32(1): p. 8-17.

2021

  • Pouwels, S., et al., The First Modified Delphi Consensus Statement for Resuming Bariatric and Metabolic Surgery in the COVID-19 Times. Obes Surg, 2021. 31(1): p. 451-456.
  • Kroh, M., et al., Returning to Surgery-Experience, Discussions and Consensus. Obes Surg, 2021. 31(3): p. 1336-1338.
  • Herz, C.T., et al., Active Brown Adipose Tissue is Associated With a Healthier Metabolic Phenotype in Obesity. Diabetes, 2021.
  • Herz, C.T., et al., Sex differences in brown adipose tissue activity and cold-induced thermogenesis. Mol Cell Endocrinol, 2021. 534: p. 111365.
  • Herz, C.T., et al., Characterization of endogenous bile acid composition in individuals with cold-activated brown adipose tissue. Mol Cell Endocrinol, 2021. 536: p. 111403.
  • Hamp, T., et al., Duration of safe apnea in patients with morbid obesity during passive oxygenation using high-flow nasal insufflation versus regular flow nasal insufflation, a randomized trial. Surg Obes Relat Dis, 2021. 17(2): p. 347-355.
  • Gero, D., et al., Defining Global Benchmarks in Elective Secondary Bariatric Surgery Comprising Conversional, Revisional, and Reversal Procedures. Ann Surg, 2021. 274(5): p. 821-828.
  • Felsenreich, D.M., et al., Surgical Technique of Diverted One-Anastomosis Gastric Bypass. Surg Technol Int, 2021. 39: p. 107-112.
  • Eilenberg, M., et al., Accuracy of non-invasive liver stiffness measurement and steatosis quantification in patients with severe and morbid obesity. Hepatobiliary Surg Nutr, 2021. 10(5): p. 610-622.

2020

  • Winzer, E., et al., Course of depressive symptomatology and its association with serum uric acid in one-anastomosis gastric bypass patients. Sci Rep, 2020. 10(1): p. 18405.
  • Poglitsch, M., et al., Plasma homocysteine after laparoscopic Roux-en-Y gastric bypass increases in the early postoperative phase but decreases in the long-term follow-up. A retrospective analysis. Surg Obes Relat Dis, 2020. 16(3): p. 372-380.
  • Mahawar, K.K., et al., The first consensus statement on revisional bariatric surgery using a modified Delphi approach. Surg Endosc, 2020. 34(4): p. 1648-1657.
  • Kruschitz, R., et al., Effect of one-anastomosis gastric bypass on cardiovascular risk factors in patients with vitamin D deficiency and morbid obesity: A secondary analysis. Nutr Metab Cardiovasc Dis, 2020. 30(12): p. 2379-2388.
  • Kristo, I., et al., Silent Gastroesophageal Reflux Disease in Patients with Morbid Obesity Prior to Primary Metabolic Surgery. Obes Surg, 2020. 30(12): p. 4885-4891.
  • Jedamzik, J., et al., Impact of limb length on nutritional status in one-anastomosis gastric bypass: 3-year results. Surg Obes Relat Dis, 2020. 16(4): p. 476-484.
  • Felsenreich, D.M., F.B. Langer, and G. Prager, Reply to the Letter to the Editor Concerning Anti-reflux Mucosectomy (ARMS) in Sleeve Gastrectomy Patients with GERD and Barrett's Esophagus. Obes Surg, 2020. 30(6): p. 2417-2418.
  • Felsenreich, D.M., et al., Roux-en-Y Gastric Bypass as a Treatment for Barrett's Esophagus after Sleeve Gastrectomy. Obes Surg, 2020. 30(4): p. 1273-1279.
  • Felsenreich, D.M., et al., Sleeve Gastrectomy: Surgical Technique, Outcomes, and Complications. Surg Technol Int, 2020. 36: p. 63-69.
  • Felsenreich, D.M., et al., Surgical Technique for One-Anastomosis Gastric Bypass. Surg Technol Int, 2020. 37: p. 57-61.
  • Di Lorenzo, N., et al., Clinical practice guidelines of the European Association for Endoscopic Surgery (EAES) on bariatric surgery: update 2020 endorsed by IFSO-EC, EASO and ESPCOP. Surg Endosc, 2020. 34(6): p. 2332-2358.
  • Beiglbock, H., et al., Psychopharmacological Medication Has No Influence on Vitamin Status After Bariatric Surgery in Long-term Follow-up. Obes Surg, 2020.
  • Arnoldner, M.A., et al., Pouch volume and pouch migration after Roux-en-Y gastric bypass: a comparison of gastroscopy and 3 D-CT volumetry: is there a "migration crisis"? Surg Obes Relat Dis, 2020. 16(12): p. 1902-1908.

2019

  • Winzer, E., et al., Differences in Serum Magnesium Levels in Diabetic and Non-Diabetic Patients Following One-Anastomosis Gastric Bypass. Nutrients, 2019. 11(9).
  • Wanko, B., et al., Antibody-mediated targeting of cleavage-specific OPN-T cell interactions. PLoS One, 2019. 14(4): p. e0214938.
  • Staufer, K., et al., Evaluation and comparison of six noninvasive tests for prediction of significant or advanced fibrosis in nonalcoholic fatty liver disease. United European Gastroenterol J, 2019. 7(8): p. 1113-1123.
  • Staufer, K., M. Eilenberg, and G. Prager, Author's Reply to "Liver Dysfunction with Both Roux-en-Y and One Anastomosis Gastric Bypass Is Almost Exclusively Seen with Longer Than Standard Limb Lengths" by Kamal K. Mahawar. Obes Surg, 2019. 29(1): p. 301-302.
  • Setayesh, T., et al., Impact of Weight Loss Strategies on Obesity-Induced DNA Damage. Mol Nutr Food Res, 2019. 63(17): p. e1900045.
  • Poglitsch, M., et al., Plasma homocysteine after laparoscopic Roux-en-Y gastric bypass increases in the early postoperative phase but decreases in the long-term follow-up. A retrospective analysis. Surg Obes Relat Dis, 2019.
  • Mahawar, K.K., et al., The first consensus statement on revisional bariatric surgery using a modified Delphi approach. Surg Endosc, 2019.
  • Kristo, I., et al., Modern Esophageal Function Testing and Gastroesophageal Reflux Disease in Morbidly Obese Patients. Obes Surg, 2019.
  • Jedamzik, J., et al., Impact of limb length on nutritional status in one-anastomosis gastric bypass: 3-year results. Surg Obes Relat Dis, 2019.
  • Gero, D., et al., Defining Global Benchmarks in Bariatric Surgery: A Retrospective Multicenter Analysis of Minimally Invasive Roux-en-Y Gastric Bypass and Sleeve Gastrectomy. Ann Surg, 2019. 270(5): p. 859-867.
  • Felsenreich, D.M., et al., Quality of Life 10 Years after Sleeve Gastrectomy: A Multicenter Study. Obes Facts, 2019. 12(2): p. 157-166.
  • Felsenreich, D.M., F.B. Langer, and G. Prager, Weight Loss and Resolution of Comorbidities After Sleeve Gastrectomy: A Review of Long-Term Results. Scand J Surg, 2019. 108(1): p. 3-9.
  • Felsenreich, D.M., F.B. Langer, and G. Prager, Comments on the Letter to the Editor "The Gastric Migration Crisis in Obesity Surgery". Obes Surg, 2019. 29(7): p. 2305-2306.
  • Felsenreich, D.M., et al., Surgical therapy of weight regain after Roux-en-Y gastric bypass. Surg Obes Relat Dis, 2019. 15(10): p. 1719-1728.
  • Felsenreich, D.M., et al., Roux-en-Y Gastric Bypass as a Treatment for Barrett's Esophagus after Sleeve Gastrectomy. Obes Surg, 2019.
  • Amor, M., et al., Serum Myostatin is Upregulated in Obesity and Correlates with Insulin Resistance in Humans. Exp Clin Endocrinol Diabetes, 2019. 127(8): p. 550-556.

2018

  • Xia, W., et al., Loss of ABHD15 Impairs the Anti-lipolytic Action of Insulin by Altering PDE3B Stability and Contributes to Insulin Resistance. Cell Rep, 2018. 23(7): p. 1948-1961.
  • Mahawar, K.K., et al., The First Consensus Statement on One Anastomosis/Mini Gastric Bypass (OAGB/MGB) Using a Modified Delphi Approach. Obes Surg, 2018. 28(2): p. 303-312.
  • Luger, M., et al., Changes in Bone Mineral Density Following Weight Loss Induced by One-Anastomosis Gastric Bypass in Patients with Vitamin D Supplementation. Obes Surg, 2018. 28(11): p. 3454-3465.
  • Harreiter, J., et al., Management of Pregnant Women after Bariatric Surgery. J Obes, 2018. 2018: p. 4587064.
  • Harpain, F., et al., A siphon-like retrogastric transverse colon: A case report. Int J Surg Case Rep, 2018. 44: p. 110-113.
  • Felsenreich, D.M., F.B. Langer, and G. Prager, Weight Loss and Resolution of Comorbidities After Sleeve Gastrectomy: A Review of Long-Term Results. Scand J Surg, 2018: p. 1457496918798192.
  • Felsenreich, D.M., F.B. Langer, and G. Prager, Reply to the Letter to the Editor "Does Sleeve Gastrectomy Cause Barrett's Oesophagus?". Obes Surg, 2018.
  • Felsenreich, D.M., et al., Update: 10 Years of Sleeve Gastrectomy-the First 103 Patients. Obes Surg, 2018. 28(11): p. 3586-3594.
  • Falcone, V., et al., Pregnancy after bariatric surgery: a narrative literature review and discussion of impact on pregnancy management and outcome. BMC Pregnancy Childbirth, 2018. 18(1): p. 507.
  • Eilenberg, M., et al., Significant Liver-Related Morbidity After Bariatric Surgery and Its Reversal-a Case Series. Obes Surg, 2018. 28(3): p. 812-819.
  • Amor, M., et al., Serum Myostatin is Upregulated in Obesity and Correlates with Insulin Resistance in Humans. Exp Clin Endocrinol Diabetes, 2018.

2017

  • Wagner, G., et al., HO-1 inhibits preadipocyte proliferation and differentiation at the onset of obesity via ROS dependent activation of Akt2. Sci Rep, 2017. 7: p. 40881.
  • Tardelli, M., et al., Adiponectin regulates aquaglyceroporin expression in hepatic stellate cells altering their functional state. J Gastroenterol Hepatol, 2017. 32(1): p. 253-260.
  • Staufer, K., et al., The non-invasive serum biomarker soluble Axl accurately detects advanced liver fibrosis and cirrhosis. Cell Death Dis, 2017. 8(10): p. e3135.
  • Selberherr, A., et al., "Silent" kidney stones in "asymptomatic" primary hyperparathyroidism-a comparison of multidetector computed tomography and ultrasound. Langenbecks Arch Surg, 2017. 402(2): p. 289-293.
  • Luger, M., et al., Vitamin D3 Loading Is Superior to Conventional Supplementation After Weight Loss Surgery in Vitamin D-Deficient Morbidly Obese Patients: a Double-Blind Randomized Placebo-Controlled Trial. Obes Surg, 2017. 27(5): p. 1196-1207.
  • Kruschitz, R., et al., Concerning the Manuscript "The Effect of Roux-en-Y vs Omega-Loop Gastric Bypass on Liver, Metabolic Parameters and Weight Loss". Obes Surg, 2017. 27(5): p. 1341-1342.
  • Jurets, A., et al., Upregulated TNF Expression 1 Year After Bariatric Surgery Reflects a Cachexia-Like State in Subcutaneous Adipose Tissue. Obes Surg, 2017. 27(6): p. 1514-1523.
  • Felsenreich, D.M., et al., Reflux, Sleeve Dilation, and Barrett's Esophagus after Laparoscopic Sleeve Gastrectomy: Long-Term Follow-Up. Obes Surg, 2017. 27(12): p. 3092-3101.

2016

  • Wolf, P., et al., Hormone Substitution after Gastric Bypass Surgery in Patients with Hypopituitarism Secondary to Craniopharyngioma. Endocr Pract, 2016. 22(5): p. 595-601.
  • Tardelli, M., et al., Adiponectin regulates aquaglyceroporin expression in hepatic stellate cells altering their functional state. J Gastroenterol Hepatol, 2016.
  • Luger, M., et al., Prevalence of Liver Fibrosis and its Association with Non-invasive Fibrosis and Metabolic Markers in Morbidly Obese Patients with Vitamin D Deficiency. Obes Surg, 2016.
  • Kruschitz, R., et al., The Effect of Roux-en-Y vs. Omega-Loop Gastric Bypass on Liver, Metabolic Parameters, and Weight Loss. Obes Surg, 2016.
  • Felsenreich, D.M., et al., Weight loss, weight regain, and conversions to Roux-en-Y gastric bypass: 10-year results of laparoscopic sleeve gastrectomy. Surg Obes Relat Dis, 2016. 12(9): p. 1655-1662.
  • Ekmekcioglu, C., et al., Salt taste after bariatric surgery and weight loss in obese persons. PeerJ, 2016. 4: p. e2086.

2015

  • Yasuo, S., et al., Topic: Inguinal Hernia - Unsolved problem in the daily practice. Hernia, 2015. 19 Suppl 1: p. S293-304.
  • Shakeri-Leidenmuhler, S., et al., Surgical Elimination of the Gastric Digestion by Roux-en-Y Gastric Bypass Impacts on Food Sensitisation-a Pilot Study. Obes Surg, 2015.
  • Luger, M., et al., The link between obesity and vitamin D in bariatric patients with omega-loop gastric bypass surgery - a vitamin D supplementation trial to compare the efficacy of postoperative cholecalciferol loading (LOAD): study protocol for a randomized controlled trial. Trials, 2015. 16: p. 328.
  • Luger, M., et al., Effects of omega-loop gastric bypass on vitamin d and bone metabolism in morbidly obese bariatric patients. Obes Surg, 2015. 25(6): p. 1056-62.
  • Leitner, L., et al., Immunological blockade of adipocyte inflammation caused by increased matrix metalloproteinase-cleaved osteopontin in obesity. Obesity (Silver Spring), 2015. 23(4): p. 779-85.
  • Leitner, L., et al., Osteopontin promotes aromatase expression and estradiol production in human adipocytes. Breast Cancer Res Treat, 2015. 154(1): p. 63-9.
  • Kefurt, R., et al., Hypoglycemia after Roux-En-Y gastric bypass: detection rates of continuous glucose monitoring (CGM) versus mixed meal test. Surg Obes Relat Dis, 2015. 11(3): p. 564-9.
  • Felberbauer, F.X., et al., Post-Bariatric Body-Contouring Surgery: Fewer Procedures, Less Demand, and Lower Costs. Obes Surg, 2015. 25(7): p. 1198-202.

2014

  • Itariu, B.K., et al., Insulin-Like Growth Factor 1 Predicts Post-Load Hypoglycemia following Bariatric Surgery: A Prospective Cohort Study. PLoS One, 2014. 9(4): p. e94613.
  • Borsoi, L., et al., Cushing's Syndrome in a Morbidly Obese Patient Undergoing Evaluation before Bariatric Surgery. Obes Facts, 2014. 7(3): p. 191-6.

2013

  • Zeyda, M., et al., Severe obesity increases adipose tissue expression of interleukin-33 and its receptor ST2, both predominantly detectable in endothelial cells of human adipose tissue. Int J Obes (Lond), 2013. 37(5): p. 658-65.
  • Schwameis, K., et al., The implementation of minimally-invasive esophagectomy does not impact short-term outcome in a high-volume center. Anticancer Res, 2013. 33(5): p. 2085-91.
  • Schoppmann, S.F., et al., Outcome and complications of long-term self-expanding esophageal stenting. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus / I.S.D.E, 2013. 26(2): p. 154-8.
  • Lindroos, J., et al., Human but Not Mouse Adipogenesis Is Critically Dependent on LMO3. Cell Metab, 2013. 18(1): p. 62-74.
  • Langer, F.B., et al., Weight loss and weight regain-5-year follow-up for circular- vs. linear-stapled gastrojejunostomy in laparoscopic Roux-en-Y gastric bypass. Obes Surg, 2013. 23(6): p. 776-81.

2012

  • Zeyda, M., et al., Severe obesity increases adipose tissue expression of interleukin-33 and its receptor ST2, both predominantly detectable in endothelial cells of human adipose tissue. International journal of obesity, 2012.
  • Schoppmann, S.F., et al., Outcome and complications of long-term self-expanding esophageal stenting. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus / I.S.D.E, 2012.
  • Rosenthal, R.J., et al., International Sleeve Gastrectomy Expert Panel Consensus Statement: best practice guidelines based on experience of >12,000 cases. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery, 2012. 8(1): p. 8-19.
  • Kitzinger, H.B., et al., The prevalence of body contouring surgery after gastric bypass surgery. Obesity surgery, 2012. 22(1): p. 8-12.
  • Kitzinger, H.B., et al., After massive weight loss: patients' expectations of body contouring surgery. Obesity surgery, 2012. 22(4): p. 544-8.
  • Jankovic, D., et al., Prevalence of endocrine disorders in morbidly obese patients and the effects of bariatric surgery on endocrine and metabolic parameters. Obesity surgery, 2012. 22(1): p. 62-9.
  • Itariu, B.K., et al., Long-chain n-3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial. Am J Clin Nutr, 2012. 96(5): p. 1137-49.
  • Bohdjalian, A., et al., Gastric Stimulation in the Digestive Period Modifies Length and Contractility of the Inter-digestive Period in Obese Non-diabetic and Diabetic Subjects. Obesity surgery, 2012.
  • Anderwald, C.H., et al., Alterations in gastrointestinal, endocrine, and metabolic processes after bariatric Roux-en-Y gastric bypass surgery. Diabetes Care, 2012. 35(12): p. 2580-7.

2011

  • Zeyda, M., et al., Inflammation correlates with markers of T-cell subsets including regulatory T cells in adipose tissue from obese patients. Obesity, 2011. 19(4): p. 743-8.
  • Zeyda, M., et al., Osteopontin Is an Activator of Human Adipose Tissue Macrophages and Directly Affects Adipocyte Function. Endocrinology, 2011.
  • Widhalm, K., et al., Bariatric surgery in morbidly obese adolescents: long-term follow-up. International journal of pediatric obesity : IJPO : an official journal of the International Association for the Study of Obesity, 2011. 6 Suppl 1: p. 65-9.
  • Vila, G., et al., The relationship between insulin resistance and the cardiovascular biomarker growth differentiation factor-15 in obese patients. Clin Chem, 2011. 57(2): p. 309-16.
  • Todoric, J., et al., Cross-talk between interferon-gamma and hedgehog signaling regulates adipogenesis. Diabetes, 2011. 60(6): p. 1668-76.
  • Silberhumer, G.R., et al., Long-term results after laparoscopic adjustable gastric banding in adolescent patients: follow-up of the Austrian experience. Surgical endoscopy, 2011. 25(9): p. 2993-9.
  • Rieder, E., et al., Mesh fixation in laparoscopic incisional hernia repair: glue fixation provides attachment strength similar to absorbable tacks but differs substantially in different meshes. Journal of the American College of Surgeons, 2011. 212(1): p. 80-6.
  • Promintzer-Schifferl, M., et al., Effects of Gastric Bypass Surgery on Insulin Resistance and Insulin Secretion in Nondiabetic Obese Patients. Obesity (Silver Spring), 2011.
  • Kitzinger, H.B., et al., The Prevalence of Body Contouring Surgery After Gastric Bypass Surgery. Obesity surgery, 2011.

2010

  • Zeyda, M., et al., Inflammation Correlates With Markers of T-Cell Subsets Including Regulatory T Cells in Adipose Tissue From Obese Patients. Obesity (Silver Spring), 2010.
  • Schoppmann, S.F., et al., Open versus minimally invasive esophagectomy: a single-center case controlled study. Surg Endosc, 2010.
  • Rieder, E., et al., Mesh fixation in laparoscopic incisional hernia repair: glue fixation provides attachment strength similar to absorbable tacks but differs substantially in different meshes. J Am Coll Surg, 2010. 212(1): p. 80-6.
  • Pospisilik, J.A., et al., Drosophila genome-wide obesity screen reveals hedgehog as a determinant of brown versus white adipose cell fate. Cell, 2010. 140(1): p. 148-60.
  • Langer, F.B., et al., Strategies for weight regain after sleeve gastrectomy. Surg Laparosc Endosc Percutan Tech, 2010. 20(3): p. 159-61.
  • Langer, F.B., et al., Temporary placement of self-expanding oesophageal stents as bridging for neo-adjuvant therapy. Ann Surg Oncol, 2010. 17(2): p. 470-5.
  • Langer, F.B., et al., Solving the problem of difficult stent removal due to tissue ingrowth in partially uncovered esophageal self-expanding metal stents. Ann Thorac Surg, 2010. 89(5): p. 1691-2.
  • Langer, F.B., et al., Conversion from sleeve gastrectomy to Roux-en-Y gastric bypass--indications and outcome. Obes Surg, 2010. 20(7): p. 835-40.
  • Kabon, B., et al., Supplemental postoperative oxygen and tissue oxygen tension in morbidly obese patients. Obes Surg, 2010. 20(7): p. 885-94.
  • Handisurya, A., et al., Serum vaspin concentrations in relation to insulin sensitivity following RYGB-induced weight loss. Obes Surg, 2010. 20(2): p. 198-203.
  • Bohdjalian, A., et al., Sleeve Gastrectomy as Sole and Definitive Bariatric Procedure: 5-Year Results for Weight Loss and Ghrelin. Obes Surg, 2010.

2009

  • Vila, G., et al., Plasma MR-proADM correlates to BMI and decreases in relation to leptin after gastric bypass surgery. Obesity (Silver Spring), 2009. 17(6): p. 1184-8.
  • Silberhumer, G.R., et al., Surgery for gastrointestinal stromal tumors of the stomach. J Gastrointest Surg, 2009. 13(7): p. 1213-9.
  • Silberhumer, G.R., et al., The Value of Protecting the Longitudinal Staple Line with Invaginating Sutures during Esophageal Reconstruction by Gastric Tube Pull-Up. Dig Surg, 2009. 26(4): p. 337-341.
  • Shakeri-Manesch, S., et al., Diminished upregulation of visceral adipose heme oxygenase-1 correlates with waist-to-hip ratio and insulin resistance. Int J Obes (Lond), 2009.
  • Schoppmann, S.F., et al., Fifty-five minimally invasive Esophagectomies: a single centre experience. Anticancer Res, 2009. 29(7): p. 2719-25.
  • Bohdjalian, A., et al., Improvement in glycemic control in morbidly obese type 2 diabetic subjects by gastric stimulation. Obes Surg, 2009. 19(9): p. 1221-7.
  • Bohdjalian, A., et al., Improvement in glycemic control by gastric electrical stimulation (TANTALUS) in overweight subjects with type 2 diabetes. Surg Endosc, 2009. 23(9): p. 1955-60.
  • Bohdjalian, A., et al., Circular- vs. linear-stapled gastrojejunostomy in laparoscopic Roux-en-Y gastric bypass. Obes Surg, 2009. 20(4): p. 440-6.

2008

  • Widhalm, K., et al., Bariatric surgery in morbidly obese adolescents: a 4-year follow-up of ten patients. Int J Pediatr Obes, 2008. 3 Suppl 1: p. 78-82.
  • Silberhumer, G.R., et al., Design and instrumentation of new devices for performing appendectomy at colonoscopy (with video). Gastrointest Endosc, 2008. 68(1): p. 139-45.
  • Ringhofer, C., et al., Histopathology of the endoscopic esophagogastric junction in patients with gastroesophageal reflux disease. Wien Klin Wochenschr, 2008. 120(11-12): p. 350-9.
  • Riedl, M., et al., Plasma osteopontin increases after bariatric surgery and correlates with markers of bone turnover but not with insulin resistance. J Clin Endocrinol Metab, 2008. 93(6): p. 2307-12.
  • Langer, F.B., et al., Inadequate weight loss vs secondary weight regain: laparoscopic conversion from gastric banding to Roux-en-Y gastric bypass. Obes Surg, 2008. 18(11): p. 1381-6.
  • Kiefer, F.W., et al., Osteopontin expression in human and murine obesity: extensive local up-regulation in adipose tissue but minimal systemic alterations. Endocrinology, 2008. 149(3): p. 1350-7.
  • Huber, J., et al., CC chemokine and CC chemokine receptor profiles in visceral and subcutaneous adipose tissue are altered in human obesity. J Clin Endocrinol Metab, 2008. 93(8): p. 3215-21.
  • Felberbauer, F.X., et al., Laparoscopic sleeve gastrectomy as an isolated bariatric procedure: intermediate-term results from a large series in three Austrian centers. Obes Surg, 2008. 18(7): p. 814-8.

2007

  • Ringhofer, C., et al., Videoendoscopy and histopathology of the esophagogastric junction in patients with gastroesophageal reflux disease. Wien Klin Wochenschr, 2007. 119(9-10): p. 283-90.
  • Lenglinger, J., et al., Histopathology of columnar-lined esophagus in patients with gastroesophageal reflux disease. Wien Klin Wochenschr, 2007. 119(13-14): p. 405-11.
  • Lenglinger, J., G. Prager, and M. Riegler, Adequate biopsy sampling for exclusion of columnar-lined esophagus in the obese. Obes Surg, 2007. 17(7): p. 993; author reply 994.
  • Haider, D.G., et al., Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects. J Clin Endocrinol Metab, 2007. 92(3): p. 1168-71.
  • Haider, D.G., et al., Plasma adipocyte and epidermal fatty acid binding protein is reduced after weight loss in obesity. Diabetes Obes Metab, 2007. 9(5): p. 761-3.
  • Anderwald, C., et al., The Clamp-Like Index: a novel and highly sensitive insulin sensitivity index to calculate hyperinsulinemic clamp glucose infusion rates from oral glucose tolerance tests in nondiabetic subjects. Diabetes Care, 2007. 30(9): p. 2374-80.

2006

  • Silberhumer, G.R., et al., Laparoscopic adjustable gastric banding in adolescents: the Austrian experience. Obes Surg, 2006. 16(8): p. 1062-7.
  • Langer, F.B., et al., Does gastric dilatation limit the success of sleeve gastrectomy as a sole operation for morbid obesity? Obes Surg, 2006. 16(2): p. 166-71.
  • Kaczirek, K., et al., Novel parathyroid hormone (1-84) assay as basis for parathyroid hormone monitoring in renal hyperparathyroidism. Arch Surg, 2006. 141(2): p. 129-34; discussion 134.
  • Haider, D.G., et al., Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. J Clin Endocrinol Metab, 2006. 91(4): p. 1578-81.
  • Haider, D.G., et al., Free fatty acids normalize a rosiglitazone-induced visfatin release. Am J Physiol Endocrinol Metab, 2006. 291(5): p. E885-90.
  • Bohdjalian, A., et al., One-year experience with Tantalus: a new surgical approach to treat morbid obesity. Obes Surg, 2006. 16(5): p. 627-34.
  • Bieglmayer, C., et al., Parathyroid hormone monitoring during total parathyroidectomy for renal hyperparathyroidism: pilot study of the impact of renal function and assay specificity. Clin Chem, 2006. 52(6): p. 1112-9.

2005

  • Langer, F.B., et al., Management of postoperative esophageal leaks with the Polyflex self-expanding covered plastic stent. Ann Thorac Surg, 2005. 79(2): p. 398-403; discussion 404.
  • Langer, F.B., et al., Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg, 2005. 15(7): p. 1024-9.
  • Kaczirek, K., et al., Quick PTH assay cannot predict incomplete parathyroidectomy in patients with renal hyperparathyroidism. Surgery, 2005. 137(4): p. 431-5.
  • Fleischmann, E., et al., Tissue oxygenation in obese and non-obese patients during laparoscopy. Obes Surg, 2005. 15(6): p. 813-9.

2004

  • Widhalm, K., S. Dietrich, and G. Prager, Adjustable gastric banding surgery in morbidly obese adolescents: experiences with eight patients. Int J Obes Relat Metab Disord, 2004. 28 Suppl 3: p. S42-5.
  • Stadler, A., et al., CT density measurements for characterization of adrenal tumors ex vivo: variability among three CT scanners. AJR Am J Roentgenol, 2004. 182(3): p. 671-5.
  • Schindler, K., et al., Impact of laparoscopic adjustable gastric banding on plasma ghrelin, eating behaviour and body weight. Eur J Clin Invest, 2004. 34(8): p. 549-54.
  • Prager, G., et al., Applicability of laparoscopic adrenalectomy in a prospective study in 150 consecutive patients. Arch Surg, 2004. 139(1): p. 46-9.
  • Passler, C., et al., Prognostic factors of papillary and follicular thyroid cancer: differences in an iodine-replete endemic goiter region. Endocr Relat Cancer, 2004. 11(1): p. 131-9.
  • Kaczirek, K., et al., Cytotoxic activity of camptothecin and paclitaxel in newly established continuous human medullary thyroid carcinoma cell lines. J Clin Endocrinol Metab, 2004. 89(5): p. 2397-401.
  • Bohdjalian, A., et al., [Surgical treatment of obesity]. Wien Med Wochenschr, 2004. 154(13-14): p. 329-33.

2003

  • Stift, A., et al., The early response of p53-dependent proteins during radiotherapy in human rectal carcinoma and in adjacent normal tissue. Int J Oncol, 2003. 23(5): p. 1269-75.
  • Saeger, W., et al., High diagnostic accuracy of adrenal core biopsy: results of the German and Austrian adrenal network multicenter trial in 220 consecutive patients. Hum Pathol, 2003. 34(2): p. 180-6.
  • Rauhofer, U., et al., Cystic echinococcosis of the thyroid gland in children and adults. Thyroid, 2003. 13(5): p. 497-502.
  • Prager, G., et al., The role of intraoperative quick PTH measurements in primary hyperparathyroidism. Ann Ital Chir, 2003. 74(4): p. 395-9.
  • Prager, G., et al., Impact of localization studies on feasibility of minimally invasive parathyroidectomy in an endemic goiter region. J Am Coll Surg, 2003. 196(4): p. 541-8.
  • Passler, C., et al., Follicular variant of papillary thyroid carcinoma: a long-term follow-up. Arch Surg, 2003. 138(12): p. 1362-6.
  • Passler, C., et al., Application of staging systems for differentiated thyroid carcinoma in an endemic goiter region with iodine substitution. Ann Surg, 2003. 237(2): p. 227-34.
  • Niederle, B., et al., [Minimally invasive endocrine surgery: aspects of diagnostic imaging]. Wien Klin Wochenschr, 2003. 115 Suppl 2: p. 10-8.
  • Kaczirek, K., et al., Nesidioblastosis in adults: a challenging cause of organic hyperinsulinism. Eur J Clin Invest, 2003. 33(6): p. 488-92.
  • Kaczirek, K., et al., Combined transmission and (99m)Tc-sestamibi emission tomography for localization of mediastinal parathyroid glands. Nuklearmedizin, 2003. 42(5): p. 220-3.
  • Heinz-Peer, G., et al., [Imaging of tumours of the adrenal gland]. Wien Klin Wochenschr, 2003. 115 Suppl 2: p. 65-70.

2002

  • Zettinig, G., et al., [Value of a structured report for the interpretation of parathyroid scintigraphy in primary essential hyperthyroidism]. Acta Med Austriaca, 2002. 29(2): p. 68-71.
  • Zettinig, G., et al., 'Suppressed' double adenoma--a rare pitfall in minimally invasive parathyroidectomy. Horm Res, 2002. 57(1-2): p. 57-60.
  • Schindl, M., et al., Treatment of small intestinal neuroendocrine tumors: is an extended multimodal approach justified? World J Surg, 2002. 26(8): p. 976-84.
  • Prager, G., et al., Parathyroidectomy improves concentration and retentiveness in patients with primary hyperparathyroidism. Surgery, 2002. 132(6): p. 930-5; discussion 935-6.
  • Prager, G., et al., Can dynamic gadolinium-enhanced magnetic resonance imaging with chemical shift studies predict the status of adrenal masses? World J Surg, 2002. 26(8): p. 958-64.
  • Prager, G., et al., Surgical strategy in adrenal masses. Eur J Radiol, 2002. 41(1): p. 70-7.
  • Passler, C., et al., Thyroid surgery in the geriatric patient. Arch Surg, 2002. 137(11): p. 1243-8.
  • Kaczirek, K., et al., Multiple endocrine neoplasia 1--current recommendations for diagnosis and treatment. Wien Klin Wochenschr, 2002. 114(7): p. 258-66.
  • Honigschnabl, S., et al., How accurate is MR imaging in characterisation of adrenal masses: update of a long-term study. Eur J Radiol, 2002. 41(2): p. 113-22.
  • Hoda, M.R., et al., [Pregnancy and labor after adjustable gastric banding for therapy of morbid obesity]. Wien Klin Wochenschr, 2002. 114(17-18): p. 781-4.
  • Bieglmayer, C., G. Prager, and B. Niederle, Kinetic analyses of parathyroid hormone clearance as measured by three rapid immunoassays during parathyroidectomy. Clin Chem, 2002. 48(10): p. 1731-8.

2001

  • Zettinig, G., et al., Images in thyroidology. A man with a 99mTc-pertechnetate-enhancing mediastinal mass. Thyroid, 2001. 11(8): p. 805.
  • Prager, G., et al., Minimally invasive open parathyroidectomy in an endemic goiter area: a prospective study. Arch Surg, 2001. 136(7): p. 810-6.
  • Felberbauer, F.X., G. Prager, and E. Wenzl, The inflatable band and exercise machines. Obes Surg, 2001. 11(4): p. 532.

2000

  • Neunteufl, T., et al., Effects of successful parathyroidectomy on altered arterial reactivity in patients with hypercalcaemia: results of a 3-year follow-up study. Clin Endocrinol (Oxf), 2000. 53(2): p. 229-33.

1999

  • Scheuba, C., et al., Is medullary thyroid cancer predictable? A prospective study of 86 patients with abnormal pentagastrin tests. Surgery, 1999. 126(6): p. 1089-95; discussion 1096.
  • Prager, G., et al., [The value of preoperative localization studies in primary hyperparathyroidism]. Chirurg, 1999. 70(10): p. 1082-8.
  • Passler, C., et al., Anaplastic (undifferentiated) thyroid carcinoma (ATC). A retrospective analysis. Langenbecks Arch Surg, 1999. 384(3): p. 284-93.

1991

  • Kraupp, M., et al., Adenine and hypoxanthine transport in human erythrocytes: distinct substrate effects on carrier mobility. Biochim Biophys Acta, 1991. 1070(1): p. 157-62.

„Bis zu 80% der Typ-II-Diabetiker benötigen nach bariatrisch-metabolischer Chirurgie keine Medikamente mehr. Das ist keine Statistik - das sind Menschen, die ihr Leben zurückbekommen.“

Univ.-Prof. Dr. Gerhard Prager

Evidenz trifft Empathie.

Wissenschaftliche Exzellenz ist die Grundlage - aber im Mittelpunkt steht immer der Mensch.

+43 660 489 58 51 Jetzt Termin anfragen

Nach telefonischer Terminvereinbarung